UBS Group’s Theriva Biologics TOVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
1
-7,850
| -100% | – | ﹤0.01% | 9343 |
|
|
2025
Q1 | $8.64K | Sell |
7,851
-8,555
| -52% | -$9.41K | ﹤0.01% | 7426 |
|
|
2024
Q4 | $28.7K | Sell |
16,406
-1,445
| -8% | -$2.53K | ﹤0.01% | 6413 |
|
|
2024
Q3 | $24.6K | Buy |
17,851
+17,848
| +594,933% | +$24.6K | ﹤0.01% | 6042 |
|
|
2024
Q2 | $1 | Hold |
3
| – | – | ﹤0.01% | 8274 |
|
|
2024
Q1 | $1 | Hold |
3
| – | – | ﹤0.01% | 8040 |
|
|
2023
Q4 | $1 | Buy |
+3
| New | +$1 | ﹤0.01% | 7994 |
|
|
2023
Q3 | – | Sell |
-5,933
| Closed | -$5.93K | – | 8688 |
|
|
2023
Q2 | $5.93K | Buy |
+5,933
| New | +$5.93K | ﹤0.01% | 6336 |
|
|
2023
Q1 | – | Sell |
-5,015
| Closed | -$2.31K | – | 9022 |
|
|
2022
Q4 | $2.31K | Sell |
5,015
-1,751
| -26% | -$805 | ﹤0.01% | 8503 |
|
|
2022
Q3 | $7K | Buy |
6,766
+2,677
| +65% | +$2.77K | ﹤0.01% | 7803 |
|
|
2022
Q2 | $1K | Sell |
4,089
-75,762
| -95% | -$18.5K | ﹤0.01% | 8922 |
|
|
2022
Q1 | $23K | Sell |
79,851
-17,527
| -18% | -$5.05K | ﹤0.01% | 6263 |
|
|
2021
Q4 | $26K | Buy |
97,378
+44,867
| +85% | +$12K | ﹤0.01% | 6436 |
|
|
2021
Q3 | $24K | Buy |
52,511
+52,452
| +88,902% | +$24K | ﹤0.01% | 5847 |
|
|
2021
Q2 | $0 | Sell |
59
-576,868
| -100% | – | ﹤0.01% | 8594 |
|
|
2021
Q1 | $393K | Buy |
+576,927
| New | +$393K | ﹤0.01% | 4103 |
|
|
2020
Q4 | – | Sell |
-86
| Closed | – | – | 7638 |
|
|
2020
Q3 | $0 | Sell |
86
-25,059
| -100% | – | ﹤0.01% | 7393 |
|
|
2020
Q2 | $13K | Sell |
25,145
-82,077
| -77% | -$42.4K | ﹤0.01% | 5995 |
|
|
2020
Q1 | $34K | Buy |
107,222
+106,850
| +28,723% | +$33.9K | ﹤0.01% | 5233 |
|
|
2019
Q4 | $0 | Sell |
372
-27,055
| -99% | – | ﹤0.01% | 7189 |
|
|
2019
Q3 | $12K | Buy |
27,427
+26,827
| +4,471% | +$11.7K | ﹤0.01% | 6094 |
|
|
2019
Q2 | $0 | Sell |
600
-3,378
| -85% | – | ﹤0.01% | 7148 |
|
|
2019
Q1 | $2K | Sell |
3,978
-19,658
| -83% | -$9.88K | ﹤0.01% | 6631 |
|
|
2018
Q4 | $13K | Buy |
23,636
+22,875
| +3,006% | +$12.6K | ﹤0.01% | 6179 |
|
|
2018
Q3 | $2K | Sell |
761
-162,450
| -100% | -$427K | ﹤0.01% | 6822 |
|
|
2018
Q2 | $39K | Sell |
163,211
-53,450
| -25% | -$12.8K | ﹤0.01% | 5290 |
|
|
2018
Q1 | $69K | Buy |
216,661
+44,011
| +25% | +$14K | ﹤0.01% | 4644 |
|
|
2017
Q4 | $88K | Sell |
172,650
-112,797
| -40% | -$57.5K | ﹤0.01% | 4515 |
|
|
2017
Q3 | $267K | Buy |
285,447
+80,274
| +39% | +$75.1K | ﹤0.01% | 3840 |
|
|
2017
Q2 | $117K | Sell |
205,173
-9,184
| -4% | -$5.24K | ﹤0.01% | 4199 |
|
|
2017
Q1 | $135K | Buy |
214,357
+20,038
| +10% | +$12.6K | ﹤0.01% | 4053 |
|
|
2016
Q4 | $148K | Buy |
194,319
+52,941
| +37% | +$40.3K | ﹤0.01% | 4130 |
|
|
2016
Q3 | $243K | Sell |
141,378
-177
| -0.1% | -$304 | ﹤0.01% | 3608 |
|
|
2016
Q2 | $255K | Sell |
141,555
-146,812
| -51% | -$264K | ﹤0.01% | 3602 |
|
|
2016
Q1 | $680K | Buy |
288,367
+228,037
| +378% | +$538K | ﹤0.01% | 2914 |
|
|
2015
Q4 | $138K | Buy |
60,330
+8,483
| +16% | +$19.4K | ﹤0.01% | 4015 |
|
|
2015
Q3 | $118K | Buy |
+51,847
| New | +$118K | ﹤0.01% | 4093 |
|
|
2015
Q2 | – | Sell |
-6,276
| Closed | -$14K | – | 6882 |
|
|
2015
Q1 | $14K | Sell |
6,276
-7,830
| -56% | -$17.5K | ﹤0.01% | 5662 |
|
|
2014
Q4 | $21K | Buy |
+14,106
| New | +$21K | ﹤0.01% | 5512 |
|